Aprea Therapeutics

(NASDAQ) APRE

Current Price$0.98

Market Cap$12.13M

Since IPO (2022)-93%

5 Year-99%

1 Year-41%

1 Month+40%

Aprea Therapeutics Financials at a Glance

Market Cap

$12.13M

Revenue (TTM)

$285.76K

Net Income (TTM)

$12.60M

EPS (TTM)

$-1.97

P/E Ratio

-0.50

Dividend

$0.00

Beta (Volatility)

-0.80 (Low)

Dividend

$0.00

Beta (Volatility)

-0.80 (Low)

Price

$0.98

Volume

974,589.996

Open

$0.93

Price

$0.98

Volume

974,589.996

Open

$0.93

Previous Close

$0.98

Daily Range

$0.90 - $1.06

52-Week Range

$0.55 - $2.22

Dividend

$0.00

Beta (Volatility)

-0.80 (Low)

Price

$0.98

Volume

974,589.996

Open

$0.93

Previous Close

$0.98

Daily Range

$0.90 - $1.06

52-Week Range

$0.55 - $2.22

APRE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aprea Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Oren Gilad, PhD

Website

www.aprea.com

Headquarters

Boston, MA 02116, US

APRE Financials

Key Financial Metrics (TTM)

Gross Margin

92%

Operating Margin

-46%

Net Income Margin

-44%

Return on Equity

-75%

Return on Capital

-1%

Return on Assets

-79%

Earnings Yield

-2.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.13M

Shares Outstanding

12.38M

Volume

974.59K

Avg. Volume

446.29K

Financials (TTM)

Gross Profit

$264.04K

Operating Income

$13.23M

EBITDA

$13.23M

Operating Cash Flow

$12.89M

Capital Expenditure

$0.00

Free Cash Flow

$12.89M

Cash & ST Invst.

$14.60M

Total Debt

$0.00

Aprea Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$3.34K

-98.4%

Gross Profit

$4.38M

+303.5%

Gross Margin

1313.25%

N/A

Market Cap

$12.13M

N/A

Market Cap/Employee

$1.52M

N/A

Employees

N/A

Net Income

$2.46M

+15.2%

EBITDA

$2.64M

+18.1%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$14.60M

-36.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-79.08%

N/A

Return on Invested Capital

-1.00%

N/A

Free Cash Flow

$3.07M

+12.6%

Operating Cash Flow

$3.07M

+12.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

APVOAptevo Therapeutics Inc.

APVOAptevo Therapeutics Inc.$4.97+2.26%

KPRXKiora Pharmaceuticals, Inc.

KPRXKiora Pharmaceuticals, Inc.$2.45+0.00%

INABIN8bio, Inc.

INABIN8bio, Inc.$1.58-1.25%

RNAZTransCode Therapeutics, Inc.

RNAZTransCode Therapeutics, Inc.$7.32-4.31%

BCDABioCardia, Inc.

BCDABioCardia, Inc.$1.11+1.83%

CELZCreative Medical Technology Holdings, Inc.

CELZCreative Medical Technology Holdings, Inc.$2.31+0.87%

ACXPAcurx Pharmaceuticals, Inc.

ACXPAcurx Pharmaceuticals, Inc.$2.09-1.42%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

RXTRackspace Technology

RXTRackspace Technology$5.49+0.56%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.62+0.08%

IRENIren

IRENIren$61.20+0.08%

NOKNokia

NOKNokia$12.82+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.28+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.57-0.07%

EOSEEos Energy Enterprises

EOSEEos Energy Enterprises$8.01+0.26%

Questions About APRE

What is the current price of Aprea Therapeutics?

Aprea Therapeutics is trading at $0.98 per share.

What is the 52-week range for Aprea Therapeutics?

Over the past 52 weeks, Aprea Therapeutics has traded between $0.55 and $2.22.

How much debt does Aprea Therapeutics have?

As of the most recent reporting period, Aprea Therapeutics reported total debt of N/A.

How much cash does Aprea Therapeutics have on hand?

Aprea Therapeutics reported $14.60M in cash and cash equivalents in its most recent financial results.

What is Aprea Therapeutics’s dividend yield?

Aprea Therapeutics does not currently have a dividend yield.

Aprea Therapeutics

Aprea Therapeutics Financials at a Glance

APRE News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Aprea Therapeutics

APRE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Aprea Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About APRE

What is the current price of Aprea Therapeutics?

What is the 52-week range for Aprea Therapeutics?

How much debt does Aprea Therapeutics have?

How much cash does Aprea Therapeutics have on hand?

What is Aprea Therapeutics’s dividend yield?

Premium Investing Services